Medaphor Group PLC ScanNav AI software featured on ITV
May 14 2018 - 1:00AM
RNS Non-Regulatory
TIDMMED
Medaphor Group PLC
14 May 2018
MedaPhor Group plc
("MedaPhor" or the "Group" or the "Company")
ScanNav AI software featured on ITV
MedaPhor Group plc (AIM: MED), the intelligent ultrasound
software and simulation company, announces its artificial
intelligence ("AI") based real-time image analysis software,
ScanNav(TM) has featured on the ITV 'Wales This Week'
programme.
ScanNav uses deep learning-based algorithms to automatically
identify, grade and capture good ultrasound images to provide
real-time guidance, assessment and audit of obstetric scanning. It
is believed to be the first AI system to carry out an automated,
real-time "peer review" of obstetric ultrasound images as the
patient is scanned.
The technology is currently being piloted at the Fetal Medicine
Department of St George's University Hospitals NHS Trust in London,
UK.
Nicholas Sleep, Chief Technology Officer at MedaPhor, commented:
"The initial feedback from the pilot of our ScanNav AI software in
St George's Hospital, London has been very positive. After
expanding the pilot over the coming months, we look forward to
ScanNav being used more widely to improve ultrasound scanning for
patients."
The feature is available to view on the Company website here:
https://www.medaphor.com/tomorrows-ai-ultrasound-technology-is-here-scannav-debuts-on-itv-news/
Enquiries:
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Ian Whittaker, COO
Cenkos Securities Tel: +44 (0)20 7397 8900
Camilla Hume (Nominated Advisor)
Michael Johnson / Julian Morse (Corporate
Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com
Paul McManus / Anna Dunphy Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876
741 001
About MedaPhor (www.investors.medaphor.com)
MedaPhor (AIM: MED), the intelligent ultrasound software and
simulation company, develops artificial intelligence-based clinical
image analysis software tools, augmented reality-based needle
guidance software and advanced hi-fidelity haptic and manikin-based
training simulators for medical practitioners.
Based in Cardiff and Oxford in the UK, Atlanta in the US and
Hong Kong in Asia, MedaPhor operates two divisions:
Intelligent Ultrasound Simulation Division
Focuses on hi-fidelity ultrasound education and training through
simulation. Its three main products are the ScanTrainer OBGYN and
General Medical simulator training platform, the HeartWorks
echocardiography simulator platform and the BodyWorks Eve Point of
Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators
have been sold to over 300 medical institutions in over 30
countries around the world.
Intelligent Ultrasound Clinical Division
Focuses on augmented reality and deep-learning based algorithms
to make ultrasound machines smarter and more accessible. Products
in development include ScanNav and NeedleGuide. ScanNav uses
machine-learning based algorithms to automatically identify, grade
and capture good ultrasound images. NeedleGuide aims to simplify
ultrasound-guided needling by using deep learning and augmented
reality to provide the user with pathway guidance and automated
tracking for a range of medical procedures.
Some products in the pipeline may require US FDA approval, as
such this material should be considered informational only and does
not constitute an offer to sell or infer claims or benefits.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALLFEAEDIVLIT
(END) Dow Jones Newswires
May 14, 2018 02:00 ET (06:00 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Jul 2023 to Jul 2024